G-15: Selective GPR30 Antagonist for Precision Estrogen Signaling Research

Executive Summary: G-15 (CAS 1161002-05-6) is a highly selective antagonist of GPR30, with a Ki of ~20 nM, and shows minimal activity toward ERα/ERβ at high concentrations (APExBIO); it inhibits GPR30-mediated calcium mobilization and PI3K/Akt signaling in vitro (IC50 ~185 nM for calcium blockade in SKBr3 cells) (Wang et al., 2021); in vivo, it impairs estrogen-dependent immune and cognitive functions in ovariectomized rats; G-15 is insoluble in water/ethanol but highly soluble in DMSO (≥37 mg/mL); and it is widely adopted for dissecting non-genomic estrogen pathways in neurobiology, cancer, and immunology (related guide).

Biological Rationale

G-15 targets the G protein-coupled estrogen receptor 30 (GPR30, also known as GPER1), a non-classical estrogen receptor localized primarily in the endoplasmic reticulum. GPR30 mediates rapid, non-genomic cellular responses to ligands such as estradiol, including calcium mobilization and PI3K/Akt pathway activation (Wang et al., 2021). Classical estrogen receptors, ERα and ERβ, primarily regulate gene transcription. GPR30 is functionally distinct, contributing to rapid signaling events important in immune regulation, neuroprotection, and cancer proliferation. In models of hemorrhagic shock, GPR30—alongside ERα—mediates estradiol's protective effects on immune cell function and endoplasmic reticulum stress attenuation (Wang et al., 2021). Thus, selective antagonism of GPR30 is crucial for dissecting non-genomic estrogen signaling in physiological and pathological contexts.

Mechanism of Action of G-15

G-15 is a non-steroidal, high-affinity GPR30 antagonist with a Ki of ~20 nM. It binds the GPR30 receptor without appreciable affinity for ERα or ERβ at concentrations up to 10 μM (APExBIO). G-15 inhibits GPR30-mediated signaling by blocking estradiol- or G-1-induced intracellular calcium mobilization and PI3K activation. This leads to reduced Akt phosphorylation and downstream signaling changes. In SKBr3 breast cancer cells, G-15 dose-dependently inhibits G-1-stimulated calcium mobilization (IC50 ~185 nM), confirming its functional antagonism in vitro. In animal models, G-15 blocks estradiol-dependent immune cell proliferation and neuroprotective effects, further validating its specificity (Wang et al., 2021). Importantly, G-15 does not activate classical estrogen response elements or modulate nuclear receptor transcription.

Evidence & Benchmarks

• G-15 binds GPR30 with a Ki of ~20 nM, demonstrating high selectivity over ERα/ERβ (APExBIO, product page).
• In SKBr3 cells, G-15 inhibits G-1-induced intracellular Ca²⁺ mobilization with IC50 ≈185 nM (Wang et al., 2021).
• G-15 reverses G-1-stimulated cell proliferation in vitro (Wang et al., Table 1, DOI).
• In ovariectomized female rats, subcutaneous G-15 (5–10 μg/day) impairs estradiol-driven spatial learning in behavioral assays (Wang et al., 2021).
• G-15 blocks estradiol-mediated normalization of CD4+ T lymphocyte proliferation and cytokine production post-hemorrhagic shock (Wang et al., Figure 1, DOI).
• No significant ERα or ERβ antagonism observed at ≤10 μM, indicating minimal off-target activity (APExBIO).

For a critical review of G-15 in advanced mechanistic contexts, see this article, which this dossier extends by providing detailed storage, solubility, and dose-activity benchmarks relevant for reproducibility.

Applications, Limits & Misconceptions

Researchers use G-15 to dissect GPR30-mediated signaling in neurobiology, immunology, and cancer biology. Its selectivity enables precise differentiation of GPR30 versus classical ER pathways. G-15 is instrumental in intracellular calcium mobilization assays, PI3K/Akt pathway modulation, and immune function models. It is validated as a molecular probe in neurodegenerative disease studies and estrogen-driven cancer models.

For a translational perspective on G-15's impact in immune modulation and cancer biology, see this comparison; the current article clarifies how G-15 benchmarks translate into experimental design choices and troubleshooting strategies.

Common Pitfalls or Misconceptions

• G-15 does not antagonize ERα or ERβ at standard experimental concentrations (≤10 μM); do not use as a general estrogen receptor antagonist (APExBIO).
• G-15 is insoluble in water or ethanol; improper vehicle selection (e.g., PBS) results in precipitation and loss of activity.
• Long-term storage of G-15 solutions in DMSO at room temperature leads to degradation; always store stock at -20°C and prepare fresh working dilutions.
• G-15's effects are specific to GPR30-mediated pathways; nuclear estrogen signaling is not blocked.
• Warming and ultrasonication are necessary for dissolving at high concentrations; skipping this step can yield incomplete solubilization and inaccurate dosing.

For troubleshooting and optimal workflow integration, see this workflow guide; the present dossier updates solubility and storage recommendations.

Workflow Integration & Parameters

G-15 is supplied as a solid with molecular weight 370.24 and chemical formula C₁₉H₁₆BrNO₂. It is insoluble in water and ethanol but dissolves in DMSO at concentrations ≥37 mg/mL. For experimental use, stock solutions (>10 mM) should be prepared in DMSO, aliquoted, and stored at -20°C. Avoid repeated freeze-thaw cycles and prepare working dilutions fresh on the day of use. Warming and ultrasonic treatment facilitate complete dissolution.

In vitro, typical working concentrations range from 100 nM to 10 μM, depending on cell type and assay. In SKBr3 cellular calcium mobilization assays, IC50 is ~185 nM. In vivo, subcutaneous doses of 5 or 10 μg/day are effective in rodent models for probing GPR30 function (Wang et al., 2021).

For further method optimization and comparative antagonist analysis, see this article; this dossier extends the discussion with updated in vivo dose-response data and practical tips for compound handling.

Conclusion & Outlook

G-15 is a validated, highly selective tool for dissecting GPR30-mediated estrogen signaling. Its robust in vitro and in vivo benchmarks, combined with well-characterized solubility and storage properties, make it indispensable for research in neurobiology, immunology, and cancer biology. For authoritative sourcing and technical support, APExBIO provides comprehensive documentation and technical advice (product page). As estrogen signaling research advances, G-15's specificity will remain crucial for parsing non-genomic versus nuclear estrogen receptor actions.